Skip to main content
N4 PHARMA PLC logo

N4 PHARMA PLC — Investor Relations & Filings

Ticker · N4P ISIN · GB00BYW8QM32 LEI · 213800I841D2RKMFK955 IL Professional, scientific and technical activities
Open in API
Filings indexed 840 across all filing types
Latest filing 2021-07-20 Major Shareholding Noti…
Country GB United Kingdom
Listing IL N4P

About N4 PHARMA PLC

https://n4pharma.com/

N4 Pharma PLC is a specialist pharmaceutical company focused on the development of Nuvec®, its proprietary silica nanoparticle delivery system. This platform technology is designed to enhance the cellular delivery and potency of nucleic acid-based treatments, such as vaccines and cancer therapies. The company's primary focus is on applying Nuvec® to enable advanced therapies for oncology and infectious diseases. N4 Pharma's business model involves developing and out-licensing its technology to pharmaceutical and biotechnology partners to improve the performance of new and existing drugs.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly labeled with 'RNS Number : 8456F' and contains the standard header 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details a 'TR-1: Standard form for notification of major holdings' concerning an acquisition of voting rights by an individual shareholder, James Robert Kight, crossing a threshold (from 5.09% to 6.00244%). This type of mandatory disclosure regarding significant changes in share ownership is a specific regulatory filing. While it relates to shareholding changes, the most precise category for mandatory regulatory disclosures that aren't 10-K, ER, or specific meeting materials is often RNS, but given the specific nature of 'Major Shareholding Notification' (MRQ), that is a better fit than the general RNS fallback. However, the TR-1 form is a standard regulatory notification. Reviewing the definitions, 'Major Shareholding Notification (Code: MRQ)' fits perfectly as it covers 'Notification of changes in significant share ownership levels (crossing thresholds)'. The document is the notification itself, not an announcement of a report.
2021-07-20 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is clearly identified by the header 'RNS Number : 5548F' and contains the standard footer information for RNS (Regulatory News Service) releases from the London Stock Exchange. The content itself is a 'TR-1: Standard form for notification of major holdings,' which details changes in voting rights held by a person subject to notification obligations (James Robert Kight crossing the 5% threshold). This type of mandatory disclosure regarding significant share ownership changes falls under the category of Major Shareholding Notification (MRQ). Although RNS is present, MRQ is a more specific classification for this content type.
2021-07-16 English
Holding(s) in Company
Regulatory Filings Classification · 1% confidence The document is explicitly labeled with "RNS Number : 2247F" and contains the standard header/footer information associated with Regulatory News Service (RNS) announcements from the London Stock Exchange. The content details a "TR-1: Standard form for notification of major holdings" concerning an acquisition or disposal of voting rights by an individual shareholder (James Robert Kight). This type of filing, which reports changes in significant share ownership crossing notification thresholds, directly corresponds to the Major Shareholding Notification category. Although RNS is the distribution mechanism, the specific content dictates the classification as Major Shareholding Notification (MRQ) rather than the general fallback (RNS).
2021-07-14 English
Result of AGM and Business Update
AGM Information Classification · 1% confidence The document is titled 'Result of AGM and Business Update' and explicitly states that it is providing an update 'following today's Annual General Meeting, at which all resolutions were duly passed.' It also mentions that the AGM voting results will be available on the website later today. This content directly relates to the proceedings and outcomes of the Annual General Meeting. While it contains a business update, the primary context and trigger for the announcement is the AGM result. Therefore, the most specific classification is AGM Information (AGM-R). It is not a DEF 14A (Remuneration) or a DVA (Declaration of Voting Results), as it is an update *following* the AGM, not the formal results document itself, although it references where those results will be posted.
2021-07-13 English
Holding(s) in Company
Major Shareholding Notification Classification · 1% confidence The document is explicitly titled 'TR-1: Standard form for notification of major holdings' and contains details about an 'acquisition or disposal of voting rights' by an individual shareholder (James Robert Kight), including the date the threshold was crossed and the resulting percentage of voting rights (3.640000%). This structure is characteristic of regulatory filings related to insider or major shareholder transactions, which aligns with the definition of Director's Dealing (DIRS) or a general regulatory filing. Since the transaction involves a director/executive (implied by the nature of the filing, though not explicitly stated as a director, it is a major holding notification), and the document is a standardized regulatory form (TR-1), the most specific category is Director's Dealing (DIRS). However, the definition for DIRS is 'Report of personal share transactions by company directors and executives (insider trades)'. While this is a major holding notification, the TR-1 form is the standard mechanism for reporting changes in major shareholdings, which often includes directors but also any entity crossing the 3% threshold. Given the options, 'Director's Dealing (DIRS)' is the closest fit for insider/major shareholder transaction reporting, but 'Major Shareholding Notification (MRQ)' is defined as 'Notification of changes in significant share ownership levels (crossing thresholds)'. Since the document explicitly reports crossing a threshold and details the resulting holding, MRQ is the most precise fit based on the provided definitions.
2021-07-13 English
Early data for SFX-01 in leukaemia cell lines
Regulatory Filings Classification · 1% confidence The document begins with an 'RNS Number' and is dated July 13, 2021. It announces preclinical data regarding the drug SFX-01 in leukaemia cell lines. The text concludes with boilerplate language indicating it was distributed via 'Reach', a non-regulatory press release distribution service of RNS, and explicitly states, 'Reach is a non-regulatory news service.' This structure—a press release format containing operational/scientific updates, distributed via a non-regulatory channel (Reach/RNS)—points towards a general regulatory announcement or press release that doesn't fit a specific financial report category (like 10-K, ER, or IR). Since it is a general announcement that doesn't fit the more specific categories (like DIRS, DIV, CAP, etc.), the most appropriate fallback category is Regulatory Filings (RNS). The document length is moderate (5681 chars), but the content is an announcement of data, not the full report itself.
2021-07-13 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.